Estimated read time: Less than a minute
This archived news story is available only for your personal, non-commercial use. Information in the story may be outdated or superseded by additional information. Reading or replaying the story in its archived form does not constitute a republication of the story.
NEW YORK (AP) — Johnson & Johnson said Friday that is in early talks to buy the Swiss drugmaker Actelion Pharmaceuticals.
Actelion Pharmaceuticals Ltd. makes high blood pressure medicines that treat arteries in the lung and around the heart. Johnson & Johnson of New Brunswick, New Jersey, develops drugs and manufactures medical devices and other consumer products.
Shares of Johnson & Johnson rose $1.06 to $114.13 Friday.
Copyright © The Associated Press. All rights reserved. This material may not be published, broadcast, rewritten or redistributed.
